These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22811919)

  • 1. Improving survival in decompensated cirrhosis.
    Mukerji AN; Patel V; Jain A
    Int J Hepatol; 2012; 2012():318627. PubMed ID: 22811919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.
    Frenette C; Kayali Z; Mena E; Mantry PS; Lucas KJ; Neff G; Rodriguez M; Thuluvath PJ; Weinberg E; Bhandari BR; Robinson J; Wedick N; Chan JL; Hagerty DT; Kowdley KV;
    J Hepatol; 2021 Feb; 74(2):274-282. PubMed ID: 33038432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
    Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural History of Cirrhosis of Liver after First Decompensation: A Prospective Study in India.
    Shah AS; Amarapurkar DN
    J Clin Exp Hepatol; 2018 Mar; 8(1):50-57. PubMed ID: 29743797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body composition predicts mortality and decompensation in compensated cirrhosis patients: A prospective cohort study.
    Tapper EB; Zhang P; Garg R; Nault T; Leary K; Krishnamurthy V; Su GL
    JHEP Rep; 2020 Feb; 2(1):100061. PubMed ID: 32039402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis.
    Wang T; Tan W; Wang X; Zheng X; Huang Y; Li B; Meng Z; Gao Y; Qian Z; Liu F; Lu X; Yan H; Zheng Y; Zhang W; Yin S; Gu W; Zhang Y; Dong F; Wei J; Deng G; Xiang X; Zhou Y; Hou Y; Zhang Q; Xiong S; Liu J; Long L; Chen R; Chen J; Jiang X; Luo S; Chen Y; Jiang C; Zhao J; Ji L; Mei X; Li J; Li T; Zheng R; Zhou X; Ren H; Shi Y; Li H;
    JHEP Rep; 2022 Oct; 4(10):100529. PubMed ID: 36052222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis.
    Torp N; Israelsen M; Madsen B; Lutz P; Jansen C; Strassburg C; Mortensen C; Knudsen AW; Sorensen GL; Holmskov U; Schlosser A; Thiele M; Trebicka J; Krag A
    JHEP Rep; 2021 Jun; 3(3):100287. PubMed ID: 34041469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort.
    Verna EC; Morelli G; Terrault NA; Lok AS; Lim JK; Di Bisceglie AM; Zeuzem S; Landis CS; Kwo P; Hassan M; Manns MP; Vainorius M; Akushevich L; Nelson DR; Fried MW; Reddy KR
    J Hepatol; 2020 Sep; 73(3):540-548. PubMed ID: 32243960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Virologic Response to Treatment on Short- and Long-term Outcomes of Patients With Chronic Hepatitis B Virus Infection and Decompensated Cirrhosis.
    Jang JW; Choi JY; Kim YS; Yoo JJ; Woo HY; Choi SK; Jun CH; Lee CH; Sohn JH; Tak WY; Lee YR; Han KH
    Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1954-1963.e3. PubMed ID: 29753085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
    Abdallah MA; Kuo YF; Asrani S; Wong RJ; Ahmed A; Kwo P; Terrault N; Kamath PS; Jalan R; Singal AK
    J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept.
    Weismüller TJ; Fikatas P; Schmidt J; Barreiros AP; Otto G; Beckebaum S; Paul A; Scherer MN; Schmidt HH; Schlitt HJ; Neuhaus P; Klempnauer J; Pratschke J; Manns MP; Strassburg CP
    Transpl Int; 2011 Jan; 24(1):91-9. PubMed ID: 20819196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline MELD score predicts hepatic decompensation during antiviral therapy in patients with chronic hepatitis C and advanced cirrhosis.
    Dultz G; Seelhof M; Herrmann E; Welker MW; Friedrich-Rust M; Teuber G; Kronenberger B; von Wagner M; Vermehren J; Sarrazin C; Zeuzem S; Hofmann WP
    PLoS One; 2013; 8(8):e71262. PubMed ID: 23936497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplant Model for End-stage Liver Disease score has no impact on posttransplant survival in living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):396-8. PubMed ID: 22410026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence and type of decompensation affects outcomes in autoimmune hepatitis upon treatment with corticosteroids.
    Sharma S; Agarwal S; Kaushal K; Anand A; Gunjan D; Yadav R; Saraya A
    JGH Open; 2021 Jan; 5(1):81-90. PubMed ID: 33490617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of Outcomes in Autoimmune Hepatitis Presenting as Acute on Chronic Liver Failure Without Extrahepatic Organ Dysfunction upon Treatment With Steroids.
    Sharma S; Agarwal S; Gopi S; Anand A; Mohta S; Gunjan D; Yadav R; Saraya A
    J Clin Exp Hepatol; 2021; 11(2):171-180. PubMed ID: 33746441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
    van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
    J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures.
    Bajaj JS; O'Leary JG; Reddy KR; Wong F; Biggins SW; Patton H; Fallon MB; Garcia-Tsao G; Maliakkal B; Malik R; Subramanian RM; Thacker LR; Kamath PS;
    Hepatology; 2014 Jul; 60(1):250-6. PubMed ID: 24677131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
    Francoz C; Belghiti J; Castaing D; Chazouillères O; Duclos-Vallée JC; Duvoux C; Lerut J; Le Treut YP; Moreau R; Mandot A; Pageaux G; Samuel D; Thabut D; Valla D; Durand F
    Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS.
    Al Sibae MR; Cappell MS
    Dig Dis Sci; 2011 Apr; 56(4):977-87. PubMed ID: 20844956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.